The latest quarterly R&D expense is $3.13 Million with a QoQ Growth of -14.00%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $3.13M.
$3.13M
$3.13 Million
Q2 FY2026 · 2026-06-30
-14.00%
vs. $3.64M prior quarter
23
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $3.13M | -14.00% | +26.04% |
| Q1 FY2026Period end 2026-03-31 | $3.64M | -20.01% | +32.53% |
| Q4 FY2025Period end 2025-12-31 | $4.55M | +68.63% | +84.26% |
| Q3 FY2025Period end 2025-09-30 | $2.70M | +8.65% | -2.07% |
| Q2 FY2025Period end 2025-06-30 | $2.48M | -9.57% | -4.09% |
| Q1 FY2025Period end 2025-03-31 | $2.75M | +11.21% | +16.44% |
| Q4 FY2024Period end 2024-12-31 | $2.47M | -10.37% | -19.12% |
| Q3 FY2024Period end 2024-09-30 | $2.76M | +6.41% | +49.03% |
| Q2 FY2024Period end 2024-06-30 | $2.59M | +9.79% | +20.34% |
| Q1 FY2024Period end 2024-03-31 | $2.36M | -22.75% | +22.47% |
| Q4 FY2023Period end 2023-12-31 | $3.06M | +65.14% | +111.71% |
| Q3 FY2023Period end 2023-09-30 | $1.85M | -14.07% | +97.86% |
| Q2 FY2023Period end 2023-06-30 | $2.15M | +11.73% | +58.19% |
| Q1 FY2023Period end 2023-03-31 | $1.93M | +33.54% | +84.23% |
| Q4 FY2022Period end 2022-12-31 | $1.44M | +54.33% | N/A |
| Q3 FY2022Period end 2022-09-30 | $935.00K | -31.30% | N/A |
| Q2 FY2022Period end 2022-06-30 | $1.36M | +30.11% | N/A |
| Q1 FY2022Period end 2022-03-31 | $1.05M | N/A | N/A |
| Q4 FY2021Period end 2021-12-31 | $0 | N/A | N/A |
| Q3 FY2021Period end 2021-09-30 | $0 | N/A | N/A |
| Q2 FY2021Period end 2021-06-30 | $0 | N/A | N/A |
| Q1 FY2021Period end 2021-03-31 | $0 | N/A | N/A |
| Q4 FY2020Period end 2020-12-31 | $0 | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
